Role of endothelial cells in antihyperalgesia induced by a triptan and β-blocker

Neuroscience

Volumn 232, Issue , 2013, Pages 83-89

  Joseph, E K ^a,b   Levine, J D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

blocker; Endothelial cell; Endothelin; Epinephrine; Hyperalgesia; Triptan

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [[(3 PHENOXYBENZYL)(1,2,3,4 TETRAHYDRO 1 NAPHTHYL)AMINO]CARBONYL]TRIMELLITIC ACID; ADRENALIN; ENDOTHELIN; OCTOXINOL 9; PROSTAGLANDIN E2; PURINERGIC P2X RECEPTOR ANTAGONIST; SUMATRIPTAN; UNCLASSIFIED DRUG; A-317491; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ENDOTHELIN 1; OCTOXINOL; PHENOL DERIVATIVE; POLYCYCLIC HYDROCARBON; PROPANOLAMINE DERIVATIVE; PURINERGIC P2X3 RECEPTOR; SEROTONIN 1 AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; TRYPTAMINE DERIVATIVE;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SPECIFICITY; ENDOTHELIUM CELL; HYPERALGESIA; MALE; MECHANICAL STIMULATION; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELINS; EPINEPHRINE; HYPERALGESIA; MALE; OCTOXYNOL; PHENOLS; POLYCYCLIC COMPOUNDS; PROPANOLAMINES; PURINERGIC P2X RECEPTOR ANTAGONISTS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, PURINERGIC P2X3; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SUMATRIPTAN; TRYPTAMINES;

EID: 84872506717     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.12.020     Document Type: Article

References (56)

1. Aley K.O., Levine J.D. Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat. J Neurosci 1997, 17:8018-8023.
2. Aley K.O., Levine J.D. Role of protein kinase A in the maintenance of inflammatory pain. J Neurosci 1999, 19:2181-2186.
3. Bodin P., Burnstock G. Synergistic effect of acute hypoxia on flow-induced release of ATP from cultured endothelial cells. Experientia 1995, 51:256-259.
4. Bourreau J.P., Banijamali H.S., Challice C.E. Modification of excitation-contraction coupling in cat ventricular myocardium following endocardial damage. Can J Physiol Pharmacol 1993, 71:254-262.
5. Chiam P.J. Topical beta-blocker treatment for migraine. Int Ophthalmol 2012, 32:85-88.
6. Classey J.D., Bartsch T., Goadsby P.J. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans. Brain Res 2010, 1361:76-85.
7. Connor H.E., Edwards L.A., Feniuk W. Neurogenically mediated contractions of dog basilar artery involve the release of a thromboxane-like substance. Eur J Pharmacol 1989, 174:205-213.
8. Diener H.C., Katsarava Z., Limmroth V. Current diagnosis and treatment of migraine. Ophthalmologe 2008, 105:501-508. quiz 509-510.
9. Diener H.C., Limmroth V. Migraine therapy. Internist (Berl) 2005, 46:1087-1095.
10. Dodick D., Silberstein S. Central sensitization theory of migraine: clinical implications. Headache 2006, 46(Suppl. 4):S182-S191.
11. Eddy M.T., Ong T.C., Clark L., Teijido O., van der Wel P.C., Garces R., Wagner G., Rostovtseva T.K., Griffin R.G. Lipid dynamics and protein-lipid interactions in 2D crystals formed with the beta-barrel integral membrane protein VDAC1. J Am Chem Soc 2012, 134:6375-6387.
12. Edvinsson L., Uddman E., Wackenfors A., Davenport A., Longmore J., Malmsjo M. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect. Clin Sci (Lond) 2005, 109:335-342.
13. Elliott D. Migraine and stroke: current perspectives. Neurol Res 2008, 30:801-812.
14. Enanche M., Volanschi E. Spectroscopic investigations of the molecular interaction of anticancer drug mitoxantrone with non-ionic surfactant micelles. J Pharm Pharmacol 2012, 64:688-696.
15. Evans R.W., Rizzoli P., Loder E., Bana D. Beta-blockers for migraine. Headache 2008, 48:455-460.
16. Farkkila M., Palo J., Saijonmaa O., Fyhrquist F. Raised plasma endothelin during acute migraine attack. Cephalalgia 1992, 12:383-384. discussion 340.
17. Firnhaber J.M., Rickett K. Clinical inquiries. What are the best prophylactic drugs for migraine?. J Fam Pract 2009, 58:608-610.
18. Goadsby P.J. Serotonin receptors and the acute attack of migraine. Clin Neurosci 1998, 5:18-23.
19. Goadsby P.J. Pathophysiology of migraine. Ann Indian Acad Neurol 2012, 15:S15-S22.
20. Greco R., Meazza C., Mangione A.S., Allena M., Bolla M., Amantea D., Mizoguchi H., Sandrini G., Nappi G., Tassorelli C. Temporal profile of vascular changes induced by systemic nitroglycerin in the meningeal and cortical districts. Cephalalgia 2011, 31:190-198.
21. Grueb M., Bartz-Schmidt K.U., Rohrbach J.M. Adrenergic regulation of cAMP/protein kinase A pathway in corneal epithelium and endothelium. Ophthal Res 2008, 40:322-328.
22. Hargreaves R.J., Shepheard S.L. Pathophysiology of migraine - new insights. Can J Neurol Sci 1999, 26(Suppl. 3):S12-S19.
23. Joseph E.K., Gear R.W., Levine J.D. Mechanical stimulation enhances endothelin-1 hyperalgesia. Neuroscience 2011, 178:189-195.
24. Joseph E.K., Levine J.D. Mitochondrial electron transport in models of neuropathic and inflammatory pain. Pain 2006, 121:105-114.
25. Kallela M., Farkkila M., Saijonmaa O., Fyhrquist F. Endothelin in migraine patients. Cephalalgia 1998, 18:329-332.
26. Khasar S.G., McCarter G., Levine J.D. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol 1999, 81:1104-1112.
27. Khasar S.G., Miao F.J., Janig W., Levine J.D. Vagotomy-induced enhancement of mechanical hyperalgesia in the rat is sympathoadrenal-mediated. J Neurosci 1998, 18:3043-3049.
28. Kilbourne E.J., Winneker R.C. Serotonin 5-HT1 receptors potentiate histamine and thrombin stimulated prostaglandin synthesis in endothelial cells. Thromb Haemost 2001, 85:924-928.
29. Kurth T. Migraine and ischaemic vascular events. Cephalalgia 2007, 27:965-975.
30. Lemos C., Neto J.L., Pereira-Monteiro J., Mendonca D., Barros J., Sequeiros J., Alonso I., Sousa A. A role for endothelin receptor type A in migraine without aura susceptibility? A study in Portuguese patients. Eur J Neurol 2011, 18:649-655.
31. Levy D. Endogenous mechanisms underlying the activation and sensitization of meningeal nociceptors: the role of immuno-vascular interactions and cortical spreading depression. Curr Pain Headache Rep 2012, 16:270-277.
32. Martin P.R., Todd J., Reece J. Effects of noise and a stressor on head pain. Headache 2005, 45:1353-1364.
33. May A. The trigeminovascular system in the human. Cerebral blood flow, functional imaging and primary headache. Nervenarzt 2003, 74:1067-1077.
34. McCrory D.C., Gray R.N. Oral sumatriptan for acute migraine. Cochrane Database Syst Rev 2012, 2:CD002915.
35. McLeod J.D., Piper P.J. Effect of K+ channel-modulating drugs on the vasoconstrictor responses of leukotrienes C4, D4 and angiotensin II in the guinea-pig isolated perfused heart. Br J Pharmacol 1992, 105:739-743.
36. McLeod J.D., Piper P.J. Effect of removing the endothelium on the vascular responses induced by leukotrienes C4 and D4 in guinea-pig isolated heart. Eur J Pharmacol 1992, 212:67-72.
37. Mink S.N., Cheng Z.Q., Bose R., Jacobs H., Kasian K., Roberts D.E., Santos-Martinez L.E., Light R.B. Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling. Am J Physiol Heart Circ Physiol 2007, 293:H3140-H3149.
38. Murphy R.M., Xu H., Latchman H., Larkins N.T., Gooley P.R., Stapleton D.I. Single fiber analyses of glycogen related proteins reveal their differential association with glycogen in rat skeletal muscle. Am J Physiol Cell Physiol 2012, 303:1146-1155.
39. Nagaraja S., Iyer S., Liu X., Eichberg J., Bond R.A. Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2-adrenoceptor activation. Br J Pharmacol 1999, 127:1099-1104.
40. Olesen J., Burstein R., Ashina M., Tfelt-Hansen P. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 2009, 8:679-690.
41. Pierce P.A., Xie G.X., Peroutka S.J., Levine J.D. Dual effect of the serotonin agonist, sumatriptan, on peripheral neurogenic inflammation. Reg Anesth 1996, 21:219-225.
42. Potrebic S., Ahn A.H., Skinner K., Fields H.L., Basbaum A.I. Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: implications for the selective antimigraine action of triptans. J Neurosci 2003, 23:10988-10997.
43. Pridgen B.C., Woon C.Y., Kim M., Thorfinn J., Lindsey D., Pham H., Chang J. Flexor tendon tissue engineering: acellularization of human flexor tendons with preservation of biomechanical properties and biocompatibility. Tissue Eng Part C Methods 2011, 17:818-828.
44. Pym R.A., Johnson R.J., Etse D.B., Eason P. Inheritance of plasma insulin-like growth factor-I and growth rate, food intake, food efficiency and abdominal fatness in chickens. Br Poult Sci 1991, 32:285-293.
45. Queen L.R., Ji Y., Xu B., Young L., Yao K., Wyatt A.W., Rowlands D.J., Siow R.C., Mann G.E., Ferro A. Mechanisms underlying beta2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells. J Physiol 2006, 576:585-594.
46. Samsam M. Central nervous system acting drugs in treatment of migraine headache. Cent Nerv Syst Agents Med Chem 2012, 12:158-172.
47. Sarvazyan N. A new approach to assess viability of adult cardiomyocytes: computer-assisted image analysis. J Mol Cell Cardiol 1998, 30:297-301.
48. Schoonman G.G., Sandor P.S., Agosti R.M., Siccoli M., Bartsch P., Ferrari M.D., Baumgartner R.W. Normobaric hypoxia and nitroglycerin as trigger factors for migraine. Cephalalgia 2006, 26:816-819.
49. Seager J.M., Clark A.H., Garland C.J. Endothelium-dependent contractile responses to 5-hydroxytryptamine in the rabbit basilar artery. Br J Pharmacol 1992, 105:424-428.
50. Shepard S.R., Ghajar J.B., Giannuzzi R., Kupferman S., Hariri R.J. Fluid percussion barotrauma chamber: a new in vitro model for traumatic brain injury. J Surg Res 1991, 51:417-424.
51. Soni SK, Singh R, Awasthi A, Singh M, Kalra A (2012) In vitro Cr(VI) reduction by cell-free extracts of chromate-reducing bacteria isolated from tannery effluent irrigated soil. Environ Sci Polluti Res Int. [Epub ahead of print].
52. Supiot F. Migraine in 2009: from attack to treatment. Rev Med Brux 2009, 30:399-403.
53. Tuncel D., Tolun F.I., Gokce M., Imrek S., Ekerbicer H. Oxidative stress in migraine with and without aura. Biol Trace Elem Res 2008, 126:92-97.
54. Tzourio C., El Amrani M., Poirier O., Nicaud V., Bousser M.G., Alperovitch A. Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism. Neurology 2001, 56:1273-1277.
55. van den Broek R.W., Bhalla P., VanDenBrink A.M., de Vries R., Sharma H.S., Saxena P.R. Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization. Cephalalgia 2002, 22:83-93.
56. Watts S.W., Gilbert L., Webb R.C. 5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats. Hypertension 1995, 26:1056-1059.